https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / Hum. Immunol. 2009 May;70(5):331-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / Hum. Immunol. 2009 May;70(5):331-92009-05-01 00:00:002019-02-15 09:19:12Melanoma vaccines: The problems of local immunosuppression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / Cancer Invest. 2009 May;27(4):361-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / Cancer Invest. 2009 May;27(4):361-82009-05-01 00:00:002019-02-15 08:50:14Tumor vaccines for breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / Prostate 2009 May;69(6):571-84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / Prostate 2009 May;69(6):571-842009-05-01 00:00:002019-02-15 08:53:02Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / J. Immunother. 2009 May;32(4):333-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / J. Immunother. 2009 May;32(4):333-402009-05-01 00:00:002019-02-15 08:48:40Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-15 / J. Cell. Biochem. 2009 Apr;106(6):999-1009
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-15 / J. Cell. Biochem. 2009 Apr;106(6):999-10092009-04-15 00:00:002019-02-15 09:17:34Nitric oxide-mediated inhibition of NFkappaB regulates hyperthermia-induced apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-11 / Urol. Oncol. 2010 May-Jun;28(3):290-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-11 / Urol. Oncol. 2010 May-Jun;28(3):290-52009-04-11 00:00:002019-02-15 08:53:01Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-10 / Cancer Immunol. Immunother. 2009 Jul;58(7):1169-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-10 / Cancer Immunol. Immunother. 2009 Jul;58(7):1169-742009-04-10 00:00:002019-02-15 08:48:09Vaccination strategies in patients with renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-08 / Eur. J. Cancer 2009 Jul;45(11):1969-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-08 / Eur. J. Cancer 2009 Jul;45(11):1969-782009-04-08 00:00:002019-02-15 08:35:44Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-01 / J. Immunol. 2009 Apr;182(7):3960-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-01 / J. Immunol. 2009 Apr;182(7):3960-42009-04-01 00:00:002019-02-15 09:21:54Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-01 / Int. J. Oncol. 2009 Apr;34(4):971-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-01 / Int. J. Oncol. 2009 Apr;34(4):971-822009-04-01 00:00:002021-11-15 17:01:56Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus
